Bullish option flow detected in Altimmune (ALT) with 8,561 calls trading, 3x expected, and implied vol increasing almost 4 points to 114.21%. Mar-25 6 calls and 3/28 weekly 5 puts are the most active options, with total volume in those strikes near 4,300 contracts. The Put/Call Ratio is 0.21. Earnings are expected on May 15th.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALT:
- Altimmune’s Promising R&D Developments and Market Opportunities Drive Buy Rating
- Altimmune call volume above normal and directionally bullish
- Evercore bullish on Altimmune, likes drug move into alcohol related disease
- Promising Potential of Altimmune’s Pemvidutide Drives Buy Rating Amid Expanding Indications and Strong Market Outlook
- Altimmune’s Pemvidutide: Promising Future with IMPACT Trial and Market Expansion